MEDTEQ Invest

Sonic Incytes is a medical device start-up company developing quantitative ultrasound for point-of-care diagnostic and procedure guidance. our mission to enable routine assessment and management of liver health, with diagnostic accuracy you can count on.

Optina Diagnostics is a diagnostics company that uses innovative retinal imaging and artificial intelligence to provide non-invasive diagnostic test results for under-diagnosed diseases. Optina Diagnostics identifies patient retinal features that assist physicians in assessing patients' health status and disease risk in order to provide timely and appropriate care. Optina Diagnostics reimagines brain health assessment and provides critical information early in disease progression.

Montreal-based My Intelligent Machines (MIMs) is a leader in artificial intelligence and systems biology. MIMs provides Biopharma companies with easy-to-implement and interactive augmented intelligence systems, allowing for accurate biological simulations at early drug development stages, to assist life scientists in the development of precisely targeted and personalized therapies.

Eli is a women's health company on a mission to improve lifelong health by continuously monitoring hormones in saliva. Hormones impact overall health every day and at all stages of life. Yet, traditional testing methods and send-out tests only provide infrequent snapshots. In three simple steps, Eli's at-home technology provides personalized hormone profiles continuously to transform how women manage their hormonal health in key areas like menopause, fertility, contraception, and endocrine conditions.

Montreal-based My Intelligent Machines (MIMs) is a leader in artificial intelligence and systems biology. MIMs provides Biopharma companies with easy-to-implement and interactive augmented intelligence systems, allowing for accurate biological simulations at early drug development stages, to assist life scientists in the development of precisely targeted and personalized therapies.

Aifred Health is a cutting-edge AI that will personalize treatment selection in depression, the world's top cause of medical impairment. Aifred addresses a decades-old trial-and-error technique to medicine selection. Almost 70% of people do not find relief after the first session, and 30% do not find relief by the fourth.

Rna Diagnostics is an early-stage molecular diagnostics company developing medical diagnostic tools to assist in the management of cancer. The company's first product, the RNA Disruption AssayTM (RDATM), is a novel test that helps oncologists rapidly assess the effectiveness of cancer chemotherapy.

Optina Diagnostics is a diagnostics company that uses innovative retinal imaging and artificial intelligence to provide non-invasive diagnostic test results for under-diagnosed diseases. Optina Diagnostics identifies patient retinal features that assist physicians in assessing patients' health status and disease risk in order to provide timely and appropriate care. Optina Diagnostics reimagines brain health assessment and provides critical information early in disease progression.

Saccade Analytics began in 2016 with Dr. Mimi Galiana, whose research at McGill University led the field of eye and head movement analysis for over 30 years. She came to understand that although her work had tremendous potential, much more was needed before it would help patients. With this goal, she founded Saccade Analytics and recruited Isabel Galiana to assist in building the business. Since then, we have grown under the mission to improve the standard of neurological care by translating advanced research into accessible tools.

Spinologics is dedicated to providing novel medical products that answer unmet clinical needs. Spinologics advantageously exploits its expertise to devise, develop, and offer improved spinal care products. Spinologics prides itself on taking ideas of merit from concept to practice.

Densitas supports value-based care through advanced healthcare analytics powered by A.I. at the patient, clinic, and system levels. Our solutions provide on-demand insights for tailored risk-based management of patients and enable healthcare administrators to monitor clinical, quality, and operational performance indicators. Our platform is uniquely designed to be fully PACS-centric by operating on the routinely archived standard DICOM images that radiologists review and supports point-of-care and retrospective processing of mammograms.

THORASYS Thoracic Medical Systems Inc. is a respiratory medical device company based in Montreal, Quebec, Canada. THORASYS applies cutting edge research and technology to the development of products for respiratory diagnosis.

MY01 offers real-time, accurate muscle pressure measurement that allows users to take timely action. MY01 capitalizes on clinically proven sensitivity and specificity for diagnosing Acute Compartment Syndrome (ACS). The company was founded in 2015 and based in Montréal, Quebec, Canada.